"Clinicopathological features and treatment outcomes of differentiated thyroid cancer in Saudi children and adults"

Journal of Otolaryngology - Head and Neck Surgery

Volumn 44, Issue 1, 2015, Pages

  AL Qahtani, Khalid Hussain ^a   Tunio, Mutahir A ^b   Al Asiri, Mushabbab ^b   Aljohani, Naji J ^b   Bayoumi, Yasser ^c   Riaz, Khalid ^b   AlShakweer, Wafa ^b  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b KING FAHAD MEDICAL CITY   (Saudi Arabia)

^c CAIRO UNIVERSITY   (Egypt)

Author keywords

Adults; Children; Clinicopathological characteristics; Differentiated thyroid cancers; Treatment outcomes

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CANCER RADIOTHERAPY; CANCER RISK; CANCER SIZE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CLINICAL EVALUATION; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIFFERENTIATED THYROID CANCER; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; GROUPS BY AGE; HUMAN; HYPOCALCEMIA; LOCAL RECURRENCE FREE SURVIVAL; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MULTIMODALITY CANCER THERAPY; NECK DISSECTION; OVERALL SURVIVAL; PRIORITY JOURNAL; SAUDI ARABIA; THYROIDECTOMY; TREATMENT OUTCOME; CANCER STAGING; EPIDEMIOLOGY; MORTALITY; PATHOLOGY; PRESCHOOL CHILD; PROCEDURES; RETROSPECTIVE STUDY; SURVIVAL RATE; THYROID NEOPLASMS; TRENDS; YOUNG ADULT;

ADOLESCENT; ADULT; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SAUDI ARABIA; SURVIVAL RATE; THYROID NEOPLASMS; THYROIDECTOMY; TREATMENT OUTCOME; YOUNG ADULT;

EID: 84946228310     PISSN: None     EISSN: 19160216     Source Type: Journal    
DOI: 10.1186/s40463-015-0102-6     Document Type: Article

References (24)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Thun MJ. Cancer statistics, 2009. CA Cancer J Clin. 2009;59:225-49.
2. Hussain F, Iqbal S, Mehmood A, Bazarbashi S, ElHassan T, Chaudhri N. Incidence of thyroid cancer in the Kingdom of Saudi Arabia, 2000-2010. Hematol Oncol Stem Cell Ther. 2013;6:58-64.
3. Jarzab B, Handkiewicz-Junak D. Differentiated thyroid cancer in children and adults: same or distinct disease? Hormones (Athens). 2007;6:200-9.
4. Kim SS, Kim SJ, Kim IJ, Kim BH, Jeon YK, Kim YK. Comparison of clinical outcomes in differentiated thyroid carcinoma between children and young adult patients. Clin Nucl Med. 2012;37:850-3.
5. Jarzab B, Handkiewicz-Junak D, Wloch J. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review. Endocr Relat Cancer. 2005;12:773-803.
6. Mihailovic J, Nikoletic K, Srbovan D. Recurrent disease in juvenile differentiated thyroid carcinoma: prognostic factors, treatments, and outcomes. J Nucl Med. 2014;55:710-7.
7. Vergamini LB, Frazier AL, Abrantes FL, Ribeiro KB, Rodriguez-Galindo C. Increase in the incidence of differentiated thyroid carcinoma in children, adolescents, and young adults: a population-based study. J Pediatr. 2014;164:1481-5.
8. Vaisman F, Corbo R, Vaisman M. Thyroid carcinoma in children and adolescents-systematic review of the literature. J Thyroid Res. 2011;2011:845362. doi:10.4061/2011/845362.
9. Dzodic R, Buta M, Markovic I, Gavrilovic D, Matovic M, Djurisic I, et al. Surgical management of well-differentiated thyroid carcinoma in children and adolescents: 33 years of experience of a single institution in Serbia. Endocr J. 2014;61:1079-86.
10. Vander Poorten V, Hens G, Delaere P. Thyroid cancer in children and adolescents. Curr Opin Otolaryngol Head Neck Surg. 2013;21:135-42.
11. Dottorini ME, Vignati A, Mazzucchelli L, Lomuscio G, Colombo L. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl Med. 1997;38:669-75.
12. Spinelli C, Bertocchini A, Antonelli A, Miccoli P. Surgical therapy of the thyroid papillary carcinoma in children: experience with 56 patients < or =16 years old. J Pediatr Surg. 2004;39:1500-5.
13. Saraiva J, Ribeiro C, Melo M, Gomes L, Costa G, Carrilho F. Thyroid carcinoma in children and young adults: retrospective review of 19 cases. Acta Med Port. 2013;26:578-82.
14. Raval MV, Bentrem DJ, Stewart AK, Ko CY, Reynolds M. Utilization of total thyroidectomy for differentiated thyroid cancer in children. Ann Surg Oncol. 2010;17:2545-53.
15. Akkari M, Makeieff M, Jeandel C, Raingeard I, Cartier C, Garrel R, et al. Thyroid surgery in children and adolescents: a series of 65 cases. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131:293-7.
16. Lazar L, Lebenthal Y, Steinmetz A, Yackobovitch-Gavan M, Phillip M. Differentiated thyroid carcinoma in pediatric patients: comparison of presentation and course between pre-pubertal children and adolescents. J Pediatr. 2009;154:708-14.
17. Zimmerman D, Hay ID, Gough IR, Goellner JR, Ryan JJ, Grant CS, et al. Papillary thyroid carcinoma in children and adults: long term follow-up of 1039 patients conservatively treated at one institution during three decades. Surgery. 1988;104:1157-66.
18. Park S, Jeong JS, Ryu HR, Lee CR, Park JH, Kang SW, et al. Differentiated thyroid carcinoma of children and adolescents: 27-year experience in the yonsei university health system. J Korean Med Sci. 2013;28:693-9.
19. Van Santen HM, Aronson DC, Vulsma T, Tummers RF, Geenen MM, de Vijlder JJ, et al. Frequent adverse events after treatment for childhood-onset differentiated thyroid carcinoma: a single institute experience. Eur J Cancer. 2004;40:1743-51.
20. Hogan AR, Zhuge Y, Perez EA, Koniaris LG, Lew JI, Sola JE. Pediatric thyroid carcinoma: incidence and outcomes in 1753 patients. J Surg Res. 2009;156:167-72.
21. Giuffrida D, Scollo C, Pellegriti G, Lavenia G, Iurato MP, Pezzin V, et al. Differentiated thyroid cancer in children and adolescents. J Endocrinol Invest. 2002;25:18-24.
22. Hay ID, Gonzalez-Losada T, Reinalda MS, Honetschlager JA, Richards ML, Thompson GB. Long-term outcome in 215 children and adolescents with papillary thyroid cancer treated during 1940 through 2008. World J Surg. 2010;34:1192-202.
23. Bongarzone I, Fugazzola L, Vigneri P, Mariani L, Mondellini P, Pacini F, et al. Age-related activation of the tyrosine kinase receptor protooncogenes RET and NTRK1 in papillary thyroid carcinoma. J Clin Endocrinol Metab. 1996;81:2006-9.
24. Ramirez R, Hsu D, Patel A, Fenton C, Dinauer C, Tuttle RM, et al. Over-expression of hepatocyte growth factor/scatter factor (HGF/SF) and the HGF/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2000;53:635-44.